Industry Speaks Out On Global Antibiotics Shortages
IGBA And AAM Offer Recommendations To Respond To International Supply Issues
Executive Summary
Responding to shortages of antibiotics seen around the world, the IGBA has insisted that the generics industry is working to address spikes in demand and has set out a series of recommendations to mitigate the situation. Meanwhile, US association the AAM has countered suggestions that supply issues are due to a “broken generic drug market.”
You may also be interested in...
IGBA Seeks To Underline Value And Access
Speaking with Generics Bulletin at the IGBA’s annual conference in February, chair Jonathan Kimball explained how the association is conveying the value of generics and biosimilars to international industry stakeholders.
Sandoz’s Saynor Reflects On Industry Challenges
In the third and final part of his exclusive interview with Generics Bulletin, Sandoz CEO Richard Saynor discusses global off-patent industry challenges including antibiotics shortages, PBM behavior in the US and the UK’s VPAS rebate mechanism.
UK Penicillin Prices Spike In January
Our Pricewatch UK feature has seen a first with WaveData’s figures for January 2023, as all nine of our top Biggest Risers belonged to the same group of medicines, penicillins.